硬皮病相关肺动脉高压的六分钟步行试验：我们计数的是关键指标吗？ - Suppr | 超能文献

Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?

作者信息

Pamidi Sushmita, Mehta Sanjay

出版信息

J Rheumatol. 2009 Feb;36(2):216-8. doi: 10.3899/jrheum.081243.

DOI:10.3899/jrheum.081243

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Six-minute walk test in scleroderma-associated pulmonary arterial hypertension: are we counting what counts?硬皮病相关肺动脉高压的六分钟步行试验：我们计数的是关键指标吗？

J Rheumatol. 2009 Feb;36(2):216-8. doi: 10.3899/jrheum.081243.

2

Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.硬皮病中间质性肺疾病和肺动脉高压患者6分钟步行试验的局限性

J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.

3

The 6-minute walk test in scleroderma--how measuring everything measures nothing.硬皮病中的6分钟步行试验——测量一切却毫无意义。

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v68-9. doi: 10.1093/rheumatology/ken273.

4

The six-minute walk test: a useful metric for the cardiopulmonary patient.六分钟步行试验：心肺疾病患者的有用指标

Intern Med J. 2009 Aug;39(8):495-501. doi: 10.1111/j.1445-5994.2008.01880.x.

5

Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.系统性硬化症患者6分钟步行试验期间每搏输出量受损的相关因素。

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):152-156. Epub 2016 Jul 22.

6

[Evaluation of exercise capacity in pulmonary arterial hypertension].[肺动脉高压运动能力评估]

Turk Kardiyol Dern Ars. 2010 Dec;38(8):580-8.

7

[Question 3-8. The shuttle walk test].[问题3 - 8. 穿梭步行试验]

Rev Mal Respir. 2005 Nov;22(5 Pt 3):7S59-7S62.

8

Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.创建一个在评估肺动脉高压治疗效果时比较6分钟步行试验与代谢当量的模型。

J Heart Lung Transplant. 2007 Jul;26(7):732-8. doi: 10.1016/j.healun.2007.04.013. Epub 2007 Jun 13.

9

Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy.强直性肌营养不良患者六分钟步行试验的可靠性和可行性

Neuromuscul Disord. 2007 Dec;17(11-12):943-9. doi: 10.1016/j.nmd.2007.08.003. Epub 2007 Sep 14.

10

Exercise as an end-point in pulmonary hypertension trials.运动作为肺动脉高压试验的一个终点指标。

Int J Clin Pract Suppl. 2010 Jan(165):4-6. doi: 10.1111/j.1742-1241.2009.02231.x.

引用本文的文献

1

Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.红细胞分布宽度作为原发性干燥综合征相关肺动脉高压患者生存的潜在预测指标：一项回顾性队列研究。

Clin Rheumatol. 2019 Feb;38(2):477-485. doi: 10.1007/s10067-018-4281-1. Epub 2018 Sep 14.

2

Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease-associated pulmonary hypertension.心率恢复是结缔组织病相关肺动脉高压患者预后的重要预测指标。

Pulm Circ. 2015 Sep;5(3):565-76. doi: 10.1086/682432.

3

Systemic sclerosis-associated pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压。

Am J Respir Crit Care Med. 2010 Jun 15;181(12):1285-93. doi: 10.1164/rccm.200909-1331PP. Epub 2010 Mar 1.